Skip Navigation

JNCI Monographs 2004 2004(32):32-39; doi:10.1093/jncimonographs/lgh026
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Pirl, W. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pirl, W. F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

2004 © Oxford University Press

ARTICLE

Evidence Report on the Occurrence, Assessment, and Treatment of Depression in Cancer Patients

William F. Pirl

Correspondence to: William F. Pirl, MD, Department of Psychiatry, The Massachusetts General Hospital, Warren 1220, 55 Fruit Street, Boston, MA 02114 (e-mail: wpirl{at}partners.org)

This evidence-based report reviews the empiric literature on depression in people with cancer with a focus on three areas: occurrence, assessment, and treatment. More than 350 studies were identified through searches of the English-language literature published between 1966 and September 2001. Reports of occurrence are limited to prevalence studies, and prevalence rates vary widely despite standardized assessments. Rates of major depressive disorder and depressive symptoms comorbid with cancer appear to be 10%-25%. Although multiple instruments are available for assessing depressive symptoms, a clinical interview using Diagnostic and Statistical Manual of Mental Disorders criteria is the standard to which assessments are compared. Some data exist for the efficacy of psychosocial and pharmacologic treatments for depression in this population. No randomized, controlled studies of alternative medicine interventions were identified. [J Natl Cancer Inst Monogr 2004;32:32-9]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JCOHome page
W. F. Pirl, J. Greer, J. S. Temel, B. Y. Yeap, and S. E. Gilman
Major Depressive Disorder in Long-Term Cancer Survivors: Analysis of the National Comorbidity Survey Replication
J. Clin. Oncol., September 1, 2009; 27(25): 4130 - 4134.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
K. Ell, B. Xie, B. Quon, D. I. Quinn, M. Dwight-Johnson, and P.-J. Lee
Randomized Controlled Trial of Collaborative Care Management of Depression Among Low-Income Patients With Cancer
J. Clin. Oncol., September 20, 2008; 26(27): 4488 - 4496.
[Abstract] [Full Text] [PDF]

Home page
 CA Cancer J ClinHome page
P. B. Jacobsen and H. S. Jim
Psychosocial Interventions for Anxiety and Depression in Adult Cancer Patients: Achievements and Challenges
CA Cancer J Clin, July 1, 2008; 58(4): 214 - 230.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
M. A Raji, P. D. Barnum, J. Freeman, and A. B Markowitz
Mirtazapine for Depression and Comorbidities in Older Patients with Cancer
Ann. Pharmacother., September 1, 2007; 41(9): 1548 - 1549.
[Full Text] [PDF]

Home page
 JCOHome page
J. S. Temel, V. A. Jackson, J. A. Billings, C. Dahlin, S. D. Block, M. K. Buss, P. Ostler, P. Fidias, A. Muzikansky, J. A. Greer, et al.
Phase II Study: Integrated Palliative Care in Newly Diagnosed Advanced Non-Small-Cell Lung Cancer Patients
J. Clin. Oncol., June 10, 2007; 25(17): 2377 - 2382.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.